id | C00004624 |
---|---|
Name | Morin / 3,5,7,2',4'-Pentahydroxyflavonol / 2-(2,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one |
CAS RN | 480-16-0 |
Standard InChI | InChI=1S/C15H10O7/c16-6-1-2-8(9(18)3-6)15-14(21)13(20)12-10(19)4-7(17)5-11(12)22-15/h1-5,16-19,21H |
Standard InChI (Main Layer) | InChI=1S/C15H10O7/c16-6-1-2-8(9(18)3-6)15-14(21)13(20)12-10(19)4-7(17)5-11(12)22-15/h1-5,16-19,21H |
Phytochemical cluster | No. 15 |
---|---|
KCF-S cluster | No. 3 |
By standard InChI | CHEMBL28626 |
---|---|
By standard InChI Main Layer | CHEMBL28626 |
By LinkDB | C10105 |
---|
By CAS RN | C008548 |
---|
class name | count |
---|---|
rosids | 8 |
family name | count |
---|---|
Moraceae | 4 |
Fabaceae | 3 |
Anacardiaceae | 1 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P33527 | Multidrug resistance-associated protein 1 | drugs | CHEMBL28626 |
CHEMBL2076023
(1)
CHEMBL2076033
(1)
|
0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL28626 |
CHEMBL1613992
(1)
|
7 / 44 |
Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | CHEMBL28626 |
CHEMBL1614529
(1)
|
0 / 0 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | CHEMBL28626 |
CHEMBL2169429
(1)
|
1 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | CHEMBL28626 |
CHEMBL1738312
(1)
|
0 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | CHEMBL28626 |
CHEMBL2169431
(1)
|
0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | CHEMBL28626 |
CHEMBL1794499
(1)
|
2 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | CHEMBL28626 |
CHEMBL1738091
(1)
|
0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL28626 |
CHEMBL1794573
(1)
|
2 / 2 |
P33765 | Adenosine receptor A3 | Adenosine receptor | CHEMBL28626 |
CHEMBL641515
(1)
|
0 / 0 |
P06746 | DNA polymerase beta | Enzyme | CHEMBL28626 |
CHEMBL1614079
(2)
|
0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | CHEMBL28626 |
CHEMBL1614076
(1)
|
1 / 1 |
P29466 | Caspase-1 | C14 | CHEMBL28626 |
CHEMBL1614158
(1)
|
0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL28626 |
CHEMBL1738600
(1)
|
0 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | CHEMBL28626 |
CHEMBL1613927
(1)
|
0 / 0 |
Q96S37 | Solute carrier family 22 member 12 | Transporter | CHEMBL28626 |
CHEMBL925845
(1)
CHEMBL925847
(1)
|
1 / 1 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | CHEMBL28626 |
CHEMBL1023248
(1)
|
1 / 1 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | CHEMBL28626 |
CHEMBL926333
(1)
|
0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | CHEMBL28626 |
CHEMBL2077116
(1)
CHEMBL2075617
(1)
|
1 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL28626 |
CHEMBL1614027
(1)
|
0 / 1 |
P54132 | Bloom syndrome protein | Enzyme | CHEMBL28626 |
CHEMBL1614522
(1)
CHEMBL1614067
(1)
|
1 / 2 |
Q9HC97 | G-protein coupled receptor 35 | Kynurenic acid receptor | CHEMBL28626 |
CHEMBL2039370
(1)
CHEMBL2039371
(1)
CHEMBL2039375 (1) CHEMBL2039376 (1) CHEMBL2039377 (1) CHEMBL2039379 (1) |
0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | CHEMBL28626 |
CHEMBL1614166
(1)
|
1 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | CHEMBL28626 |
CHEMBL1014692
(1)
CHEMBL1014697
(1)
|
0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL28626 |
CHEMBL1614458
(1)
|
0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | CHEMBL28626 |
CHEMBL1613922
(1)
CHEMBL1794486
(2)
|
0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | CHEMBL28626 |
CHEMBL1738606
(1)
|
0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | CHEMBL28626 |
CHEMBL1614377
(1)
|
0 / 1 |
Q14790 | Caspase-8 | C14 | CHEMBL28626 |
CHEMBL2014551
(1)
|
2 / 1 |
Q9Y253 | DNA polymerase eta | Enzyme | CHEMBL28626 |
CHEMBL1794569
(1)
|
1 / 1 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL28626 |
CHEMBL1614257
(4)
CHEMBL1614410
(1)
CHEMBL1614531 (4) |
1 / 3 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | CHEMBL28626 |
CHEMBL1738610
(1)
|
0 / 0 |
Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | CHEMBL28626 |
CHEMBL2169430
(1)
|
1 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL28626 |
CHEMBL1794467
(1)
|
0 / 0 |
P56817 | Beta-secretase 1 | A1A | CHEMBL28626 |
CHEMBL1771831
(1)
|
0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL28626 |
CHEMBL1613910
(1)
CHEMBL1614227
(2)
|
3 / 3 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | CHEMBL28626 |
CHEMBL1687393
(1)
CHEMBL1687394
(1)
|
2 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | CHEMBL28626 |
CHEMBL1006005
(1)
|
1 / 1 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL28626 |
CHEMBL1614038
(2)
|
2 / 2 |
P53350 | Serine/threonine-protein kinase PLK1 | PLK serine/threonine protein kinase subfamily | CHEMBL28626 |
CHEMBL985261
(1)
|
0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | CHEMBL28626 |
CHEMBL1614274
(1)
CHEMBL1613823
(1)
|
0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL28626 |
CHEMBL1614240
(1)
|
0 / 0 |
P55210 | Caspase-7 | C14 | CHEMBL28626 |
CHEMBL1613779
(1)
|
0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL28626 |
CHEMBL1614108
(1)
CHEMBL1613886
(1)
|
0 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL28626 |
CHEMBL1794483
(2)
|
0 / 0 |
Q15046 | Lysine--tRNA ligase | Enzyme | CHEMBL28626 |
CHEMBL2173401
(1)
CHEMBL2173408
(1)
|
2 / 1 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL28626 |
CHEMBL1614283
(1)
CHEMBL1614211
(4)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL28626 |
CHEMBL1614250
(1)
CHEMBL1614421
(4)
CHEMBL1614502 (4) |
4 / 3 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | CHEMBL28626 |
CHEMBL1738402
(2)
|
0 / 0 |
Q04760 | Lactoylglutathione lyase | Enzyme | CHEMBL28626 |
CHEMBL684310
(1)
|
0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL28626 |
CHEMBL1794536
(4)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL28626 |
CHEMBL1613914
(4)
|
0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | CHEMBL28626 |
CHEMBL1613829
(4)
|
0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | CHEMBL28626 |
CHEMBL1614086
(1)
CHEMBL1614034
(1)
|
1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL28626 |
CHEMBL1738442
(2)
|
0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | CHEMBL28626 |
CHEMBL1614364
(1)
|
1 / 1 |
O00255 | Menin | Unclassified protein | CHEMBL28626 |
CHEMBL1614257
(4)
CHEMBL1614531
(4)
|
2 / 5 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | CHEMBL28626 |
CHEMBL1613933
(3)
|
0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | CHEMBL28626 |
CHEMBL1613933
(3)
|
1 / 6 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C008548 | 4363 |
ABCC1
ABC29 ABCC GS-X MRP MRP1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | morin results in decreased activity of ABCC1 protein |
decreases activity
|
protein |
15670588
|
C008548 | 351 |
APP
AAA ABETA ABPP AD1 APPI CTFgamma CVAP PN-II PN2 |
amyloid beta (A4) precursor protein | morin affects the reaction [APP protein binds to APP protein] |
affects binding
/ affects reaction |
protein |
18537544
|
C008548 | 3458 |
IFNG
IFG IFI |
interferon, gamma | morin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] |
affects cotreatment
/ decreases reaction / increases abundance |
protein |
22698256
|
C008548 | 6566 |
SLC16A1
HHF7 MCT MCT1 |
solute carrier family 16 (monocarboxylate transporter), member 1 | morin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] |
decreases reaction
/ increases uptake |
protein |
17976262
|
C008548 | 54658 |
UGT1A1
BILIQTL1 GNT1 HUG-BR1 UDPGT UDPGT_1-1 UGT1 UGT1A |
UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) | UGT1A1 protein results in increased glucuronidation of morin |
increases glucuronidation
|
protein |
14557274
|
C008548 | 54575 |
UGT1A10
UDPGT UGT-1J UGT1-10 UGT1.10 UGT1J |
UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) | UGT1A10 protein results in increased glucuronidation of morin |
increases glucuronidation
|
protein |
14557274
|
C008548 | 54577 |
UGT1A7
UDPGT UDPGT_1-7 UGT-1G UGT1-07 UGT1.7 UGT1G |
UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) | UGT1A7 protein results in increased glucuronidation of morin |
increases glucuronidation
|
protein |
14557274
|
C008548 | 54576 |
UGT1A8
UDPGT UDPGT_1-8 UGT-1H UGT1-08 UGT1.8 UGT1A8S UGT1H |
UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) | UGT1A8 protein results in increased glucuronidation of morin |
increases glucuronidation
|
protein |
14557274
|
C008548 | 54600 |
UGT1A9
HLUGP4 LUGP4 UDPGT UDPGT_1-9 UGT-1I UGT1-09 UGT1-9 UGT1.9 UGT1AI UGT1I |
UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) | UGT1A9 protein results in increased glucuronidation of morin |
increases glucuronidation
|
protein |
14557274
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#210900 | Bloom syndrome; blm |
P54132
|
#607271 | Caspase 8 deficiency |
Q14790
|
#613641 | Charcot-marie-tooth disease, recessive intermediate b; cmtrib |
Q15046
|
#613916 | Deafness, autosomal recessive 89; dfnb89 |
Q15046
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#133239 | Esophageal cancer |
P04637
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#232300 | Glycogen storage disease ii |
P10253
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#220150 | Hypouricemia, renal, 1; rhuc1 |
Q96S37
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P04637
Q14790 |
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
Q92731 (marker) |
H00027 | Ovarian cancer |
P04637
(related)
|
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00108 | Autoimmune lymphoproliferative syndromes (ALPS) |
Q14790
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
Q15046
(related)
|
H00208 | Hyperbilirubinemia |
Q92887
(related)
|
H00948 | Renal hypouricemia (RHUC) |
Q96S37
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D006528 | C008548 | Carcinoma, Hepatocellular |
therapeutic
|
17950263
19539802 |
|
D056486 | C008548 | Drug-Induced Liver Injury |
therapeutic
|
17696131
|
|
D007511 | C008548 | Ischemia |
therapeutic
|
16806951
|
|
D007674 | C008548 | Kidney Diseases |
therapeutic
|
18787798
|
|
D008106 | C008548 | Liver Cirrhosis, Experimental |
therapeutic
|
18629640
|
|
D008114 | C008548 | Liver Neoplasms, Experimental |
therapeutic
|
19539802
|
|
D009374 | C008548 | Neoplasms, Experimental |
therapeutic
|
17950263
|
|
D015431 | C008548 | Weight Loss |
therapeutic
|
17950263
|